LinkedIn Profile

Access Arrowhead Research historical Linkedin company profile data on number of followers, employee headcount and more

Rows

Open dataset
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal Headcount change in past 24 months Company Name Sector Industry
nasdaq:arwr 140164 Apr 14th, 2024 12:00AM Arrowhead Pharmaceuticals 35K 495.00 Open Apr 13th, 2024 10:36PM Apr 13th, 2024 10:36PM Arrowhead Pharmaceuticals is a clinical stage, Nasdaq listed (ticker ARWR) company developing medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, our therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Our RNAi-based therapeutics are at the leading edge of genetic-based therapy with the potential to bring life changing treatments for patients. Our Targeted RNAi Molecule (TRiMTM) platform utilizes ligand-mediated delivery and is designed to enable tissue-specific targeting while being structurally simple. The TRiM platform builds on more than a decade of work on actively targeted drug delivery and offers several advantages including simplified manufacturing and reduced costs; multiple routes of administration; and potential for improved safety. Our employees are nimble, science-driven, and innovative professionals. A career at Arrowhead offers the opportunity to collaborate with top notch scientists to rapidly discover and develop RNAi-based therapeutics to add to our growing pipeline. Arrowhead’s corporate headquarters is located in Pasadena, CA. Just north of Los Angeles and resting in the foothills of the San Gabriel Mountains, Pasadena is known for its natural scenic beauty, vibrant cultural and academic environment, and rich architectural setting. Research and development activities are in Madison, WI and San Diego, California. Arrowhead’s research and development group includes fully integrated capabilities for chemistry, biology, ADME, and toxicology. We have invested heavily in our research workspaces to make sure our top-notch scientists can continue to quickly change the world in meaningful ways. Open Biotech, RNA interference, hepatitis B, alpha one anti-trypsin deficiency, Drug Development, Pharmaceuticals, and Drug delivery Open 177 E Colorado Blvd Pasadena California US 91105 Arrowhead Research Health Care Pharmaceuticals & Biotechnology
nasdaq:arwr 140164 Apr 13th, 2024 12:00AM Arrowhead Pharmaceuticals 35K 495.00 Open Apr 12th, 2024 10:27PM Apr 13th, 2024 11:03AM Arrowhead Pharmaceuticals is a clinical stage, Nasdaq listed (ticker ARWR) company developing medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, our therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Our RNAi-based therapeutics are at the leading edge of genetic-based therapy with the potential to bring life changing treatments for patients. Our Targeted RNAi Molecule (TRiMTM) platform utilizes ligand-mediated delivery and is designed to enable tissue-specific targeting while being structurally simple. The TRiM platform builds on more than a decade of work on actively targeted drug delivery and offers several advantages including simplified manufacturing and reduced costs; multiple routes of administration; and potential for improved safety. Our employees are nimble, science-driven, and innovative professionals. A career at Arrowhead offers the opportunity to collaborate with top notch scientists to rapidly discover and develop RNAi-based therapeutics to add to our growing pipeline. Arrowhead’s corporate headquarters is located in Pasadena, CA. Just north of Los Angeles and resting in the foothills of the San Gabriel Mountains, Pasadena is known for its natural scenic beauty, vibrant cultural and academic environment, and rich architectural setting. Research and development activities are in Madison, WI and San Diego, California. Arrowhead’s research and development group includes fully integrated capabilities for chemistry, biology, ADME, and toxicology. We have invested heavily in our research workspaces to make sure our top-notch scientists can continue to quickly change the world in meaningful ways. Open Biotech, RNA interference, hepatitis B, alpha one anti-trypsin deficiency, Drug Development, Pharmaceuticals, and Drug delivery Open 177 E Colorado Blvd Pasadena California US 91105 Arrowhead Research Health Care Pharmaceuticals & Biotechnology
nasdaq:arwr 140164 Apr 12th, 2024 12:00AM Arrowhead Pharmaceuticals 35K 494.00 Open Apr 11th, 2024 10:30PM Apr 12th, 2024 07:58AM Arrowhead Pharmaceuticals is a clinical stage, Nasdaq listed (ticker ARWR) company developing medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, our therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Our RNAi-based therapeutics are at the leading edge of genetic-based therapy with the potential to bring life changing treatments for patients. Our Targeted RNAi Molecule (TRiMTM) platform utilizes ligand-mediated delivery and is designed to enable tissue-specific targeting while being structurally simple. The TRiM platform builds on more than a decade of work on actively targeted drug delivery and offers several advantages including simplified manufacturing and reduced costs; multiple routes of administration; and potential for improved safety. Our employees are nimble, science-driven, and innovative professionals. A career at Arrowhead offers the opportunity to collaborate with top notch scientists to rapidly discover and develop RNAi-based therapeutics to add to our growing pipeline. Arrowhead’s corporate headquarters is located in Pasadena, CA. Just north of Los Angeles and resting in the foothills of the San Gabriel Mountains, Pasadena is known for its natural scenic beauty, vibrant cultural and academic environment, and rich architectural setting. Research and development activities are in Madison, WI and San Diego, California. Arrowhead’s research and development group includes fully integrated capabilities for chemistry, biology, ADME, and toxicology. We have invested heavily in our research workspaces to make sure our top-notch scientists can continue to quickly change the world in meaningful ways. Open Biotech, RNA interference, hepatitis B, alpha one anti-trypsin deficiency, Drug Development, Pharmaceuticals, and Drug delivery Open 177 E Colorado Blvd Pasadena California US 91105 Arrowhead Research Health Care Pharmaceuticals & Biotechnology
nasdaq:arwr 140164 Apr 11th, 2024 12:00AM Arrowhead Pharmaceuticals 35K 492.00 Open Apr 10th, 2024 10:54PM Apr 11th, 2024 10:42AM Arrowhead Pharmaceuticals is a clinical stage, Nasdaq listed (ticker ARWR) company developing medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, our therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Our RNAi-based therapeutics are at the leading edge of genetic-based therapy with the potential to bring life changing treatments for patients. Our Targeted RNAi Molecule (TRiMTM) platform utilizes ligand-mediated delivery and is designed to enable tissue-specific targeting while being structurally simple. The TRiM platform builds on more than a decade of work on actively targeted drug delivery and offers several advantages including simplified manufacturing and reduced costs; multiple routes of administration; and potential for improved safety. Our employees are nimble, science-driven, and innovative professionals. A career at Arrowhead offers the opportunity to collaborate with top notch scientists to rapidly discover and develop RNAi-based therapeutics to add to our growing pipeline. Arrowhead’s corporate headquarters is located in Pasadena, CA. Just north of Los Angeles and resting in the foothills of the San Gabriel Mountains, Pasadena is known for its natural scenic beauty, vibrant cultural and academic environment, and rich architectural setting. Research and development activities are in Madison, WI and San Diego, California. Arrowhead’s research and development group includes fully integrated capabilities for chemistry, biology, ADME, and toxicology. We have invested heavily in our research workspaces to make sure our top-notch scientists can continue to quickly change the world in meaningful ways. Open Biotech, RNA interference, hepatitis B, alpha one anti-trypsin deficiency, Drug Development, Pharmaceuticals, and Drug delivery Open 177 E Colorado Blvd Pasadena California US 91105 Arrowhead Research Health Care Pharmaceuticals & Biotechnology
nasdaq:arwr 140164 Apr 10th, 2024 12:00AM Arrowhead Pharmaceuticals 35K 491.00 Open Apr 9th, 2024 10:34PM Apr 10th, 2024 04:51PM Arrowhead Pharmaceuticals is a clinical stage, Nasdaq listed (ticker ARWR) company developing medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, our therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Our RNAi-based therapeutics are at the leading edge of genetic-based therapy with the potential to bring life changing treatments for patients. Our Targeted RNAi Molecule (TRiMTM) platform utilizes ligand-mediated delivery and is designed to enable tissue-specific targeting while being structurally simple. The TRiM platform builds on more than a decade of work on actively targeted drug delivery and offers several advantages including simplified manufacturing and reduced costs; multiple routes of administration; and potential for improved safety. Our employees are nimble, science-driven, and innovative professionals. A career at Arrowhead offers the opportunity to collaborate with top notch scientists to rapidly discover and develop RNAi-based therapeutics to add to our growing pipeline. Arrowhead’s corporate headquarters is located in Pasadena, CA. Just north of Los Angeles and resting in the foothills of the San Gabriel Mountains, Pasadena is known for its natural scenic beauty, vibrant cultural and academic environment, and rich architectural setting. Research and development activities are in Madison, WI and San Diego, California. Arrowhead’s research and development group includes fully integrated capabilities for chemistry, biology, ADME, and toxicology. We have invested heavily in our research workspaces to make sure our top-notch scientists can continue to quickly change the world in meaningful ways. Open Biotech, RNA interference, hepatitis B, alpha one anti-trypsin deficiency, Drug Development, Pharmaceuticals, and Drug delivery Open 177 E Colorado Blvd Pasadena California US 91105 Arrowhead Research Health Care Pharmaceuticals & Biotechnology
nasdaq:arwr 140164 Apr 9th, 2024 12:00AM Arrowhead Pharmaceuticals 35K 491.00 Open Apr 8th, 2024 10:44PM Apr 9th, 2024 09:32AM Arrowhead Pharmaceuticals is a clinical stage, Nasdaq listed (ticker ARWR) company developing medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, our therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Our RNAi-based therapeutics are at the leading edge of genetic-based therapy with the potential to bring life changing treatments for patients. Our Targeted RNAi Molecule (TRiMTM) platform utilizes ligand-mediated delivery and is designed to enable tissue-specific targeting while being structurally simple. The TRiM platform builds on more than a decade of work on actively targeted drug delivery and offers several advantages including simplified manufacturing and reduced costs; multiple routes of administration; and potential for improved safety. Our employees are nimble, science-driven, and innovative professionals. A career at Arrowhead offers the opportunity to collaborate with top notch scientists to rapidly discover and develop RNAi-based therapeutics to add to our growing pipeline. Arrowhead’s corporate headquarters is located in Pasadena, CA. Just north of Los Angeles and resting in the foothills of the San Gabriel Mountains, Pasadena is known for its natural scenic beauty, vibrant cultural and academic environment, and rich architectural setting. Research and development activities are in Madison, WI and San Diego, California. Arrowhead’s research and development group includes fully integrated capabilities for chemistry, biology, ADME, and toxicology. We have invested heavily in our research workspaces to make sure our top-notch scientists can continue to quickly change the world in meaningful ways. Open Biotech, RNA interference, hepatitis B, alpha one anti-trypsin deficiency, Drug Development, Pharmaceuticals, and Drug delivery Open 177 E Colorado Blvd Pasadena California US 91105 Arrowhead Research Health Care Pharmaceuticals & Biotechnology
nasdaq:arwr 140164 Apr 8th, 2024 12:00AM Arrowhead Pharmaceuticals 35K 490.00 Open Apr 7th, 2024 11:05PM Apr 8th, 2024 06:30PM Arrowhead Pharmaceuticals is a clinical stage, Nasdaq listed (ticker ARWR) company developing medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, our therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Our RNAi-based therapeutics are at the leading edge of genetic-based therapy with the potential to bring life changing treatments for patients. Our Targeted RNAi Molecule (TRiMTM) platform utilizes ligand-mediated delivery and is designed to enable tissue-specific targeting while being structurally simple. The TRiM platform builds on more than a decade of work on actively targeted drug delivery and offers several advantages including simplified manufacturing and reduced costs; multiple routes of administration; and potential for improved safety. Our employees are nimble, science-driven, and innovative professionals. A career at Arrowhead offers the opportunity to collaborate with top notch scientists to rapidly discover and develop RNAi-based therapeutics to add to our growing pipeline. Arrowhead’s corporate headquarters is located in Pasadena, CA. Just north of Los Angeles and resting in the foothills of the San Gabriel Mountains, Pasadena is known for its natural scenic beauty, vibrant cultural and academic environment, and rich architectural setting. Research and development activities are in Madison, WI and San Diego, California. Arrowhead’s research and development group includes fully integrated capabilities for chemistry, biology, ADME, and toxicology. We have invested heavily in our research workspaces to make sure our top-notch scientists can continue to quickly change the world in meaningful ways. Open Biotech, RNA interference, hepatitis B, alpha one anti-trypsin deficiency, Drug Development, Pharmaceuticals, and Drug delivery Open 177 E Colorado Blvd Pasadena California US 91105 Arrowhead Research Health Care Pharmaceuticals & Biotechnology
nasdaq:arwr 140164 Apr 7th, 2024 12:00AM Arrowhead Pharmaceuticals 34K 490.00 Open Apr 6th, 2024 10:42PM Apr 6th, 2024 10:42PM Arrowhead Pharmaceuticals is a clinical stage, Nasdaq listed (ticker ARWR) company developing medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, our therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Our RNAi-based therapeutics are at the leading edge of genetic-based therapy with the potential to bring life changing treatments for patients. Our Targeted RNAi Molecule (TRiMTM) platform utilizes ligand-mediated delivery and is designed to enable tissue-specific targeting while being structurally simple. The TRiM platform builds on more than a decade of work on actively targeted drug delivery and offers several advantages including simplified manufacturing and reduced costs; multiple routes of administration; and potential for improved safety. Our employees are nimble, science-driven, and innovative professionals. A career at Arrowhead offers the opportunity to collaborate with top notch scientists to rapidly discover and develop RNAi-based therapeutics to add to our growing pipeline. Arrowhead’s corporate headquarters is located in Pasadena, CA. Just north of Los Angeles and resting in the foothills of the San Gabriel Mountains, Pasadena is known for its natural scenic beauty, vibrant cultural and academic environment, and rich architectural setting. Research and development activities are in Madison, WI and San Diego, California. Arrowhead’s research and development group includes fully integrated capabilities for chemistry, biology, ADME, and toxicology. We have invested heavily in our research workspaces to make sure our top-notch scientists can continue to quickly change the world in meaningful ways. Open Biotech, RNA interference, hepatitis B, alpha one anti-trypsin deficiency, Drug Development, Pharmaceuticals, and Drug delivery Open 177 E Colorado Blvd Pasadena California US 91105 Arrowhead Research Health Care Pharmaceuticals & Biotechnology
nasdaq:arwr 140164 Apr 6th, 2024 12:00AM Arrowhead Pharmaceuticals 34K 490.00 Open Apr 5th, 2024 10:42PM Apr 5th, 2024 10:42PM Arrowhead Pharmaceuticals is a clinical stage, Nasdaq listed (ticker ARWR) company developing medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, our therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Our RNAi-based therapeutics are at the leading edge of genetic-based therapy with the potential to bring life changing treatments for patients. Our Targeted RNAi Molecule (TRiMTM) platform utilizes ligand-mediated delivery and is designed to enable tissue-specific targeting while being structurally simple. The TRiM platform builds on more than a decade of work on actively targeted drug delivery and offers several advantages including simplified manufacturing and reduced costs; multiple routes of administration; and potential for improved safety. Our employees are nimble, science-driven, and innovative professionals. A career at Arrowhead offers the opportunity to collaborate with top notch scientists to rapidly discover and develop RNAi-based therapeutics to add to our growing pipeline. Arrowhead’s corporate headquarters is located in Pasadena, CA. Just north of Los Angeles and resting in the foothills of the San Gabriel Mountains, Pasadena is known for its natural scenic beauty, vibrant cultural and academic environment, and rich architectural setting. Research and development activities are in Madison, WI and San Diego, California. Arrowhead’s research and development group includes fully integrated capabilities for chemistry, biology, ADME, and toxicology. We have invested heavily in our research workspaces to make sure our top-notch scientists can continue to quickly change the world in meaningful ways. Open Biotech, RNA interference, hepatitis B, alpha one anti-trypsin deficiency, Drug Development, Pharmaceuticals, and Drug delivery Open 177 E Colorado Blvd Pasadena California US 91105 Arrowhead Research Health Care Pharmaceuticals & Biotechnology
nasdaq:arwr 140164 Apr 5th, 2024 12:00AM Arrowhead Pharmaceuticals 34K 490.00 Open Apr 4th, 2024 10:52PM Apr 4th, 2024 10:52PM Arrowhead Pharmaceuticals is a clinical stage, Nasdaq listed (ticker ARWR) company developing medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, our therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Our RNAi-based therapeutics are at the leading edge of genetic-based therapy with the potential to bring life changing treatments for patients. Our Targeted RNAi Molecule (TRiMTM) platform utilizes ligand-mediated delivery and is designed to enable tissue-specific targeting while being structurally simple. The TRiM platform builds on more than a decade of work on actively targeted drug delivery and offers several advantages including simplified manufacturing and reduced costs; multiple routes of administration; and potential for improved safety. Our employees are nimble, science-driven, and innovative professionals. A career at Arrowhead offers the opportunity to collaborate with top notch scientists to rapidly discover and develop RNAi-based therapeutics to add to our growing pipeline. Arrowhead’s corporate headquarters is located in Pasadena, CA. Just north of Los Angeles and resting in the foothills of the San Gabriel Mountains, Pasadena is known for its natural scenic beauty, vibrant cultural and academic environment, and rich architectural setting. Research and development activities are in Madison, WI and San Diego, California. Arrowhead’s research and development group includes fully integrated capabilities for chemistry, biology, ADME, and toxicology. We have invested heavily in our research workspaces to make sure our top-notch scientists can continue to quickly change the world in meaningful ways. Open Biotech, RNA interference, hepatitis B, alpha one anti-trypsin deficiency, Drug Development, Pharmaceuticals, and Drug delivery Open 177 E Colorado Blvd Pasadena California US 91105 Arrowhead Research Health Care Pharmaceuticals & Biotechnology

Request a demo to view additional historical data, and much more.

Request Demo

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.

Add widgets to your dashboards

Access existing maps, charts, word clouds, and other visualizations to understand your data quickly. Or build custom widgets to view data just the way you want it.